Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Evaluate the Role of Plasma Catecholamine Levels in Predicting the Development of Myocardial Depression in Acute Neurological Patients

NCT03801694 is registered in ClinicalTrials.gov with Ohio State University as lead sponsor.

NCT NCT03801694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03801694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Evaluate the Role of Plasma Catecholamine Levels in Predicting the Development of Myocardial Depression in Acute Neurological Patients
Lead sponsor
Ohio State University
Phase
Observational
Overall status
Completed
Start date
December 3, 2018
Completion date
April 14, 2024
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke, myocardial depression, subarachnoid hemorrhage, takotsubo syndrome